通过m6A依赖的PD-1损失增强抗瘤免疫力
Chang Huang1, Xiaodong Wang2, Yinmin Gu3
1Guizhou University, Zunyi, China.
Cancer research
|August 27, 2025
概括
在PDCD1基因的N6-甲基氨酸 (m6A) 修改影响T细胞功能. 这一发现揭示了通过向m6A调节轴来增强癌症免疫疗法的新策略.
科学领域:
- 免疫学
- 表观遗传学
- 分子生物学
背景情况:
- N6-甲基氨酸 (m6A) 是一种影响基因表达和免疫反应的关键表达体修饰.
- 编程细胞死亡-1 (PD-1) 是一个关键的免疫检查点受体,调节T细胞活性,是癌症免疫治疗的目标.
研究的目的:
- 研究m6A修饰在调节PDCD1 (PD-1) 基因表达中的作用及其对T细胞功能的影响.
- 探索针对m6A-PDCD1轴改善癌症免疫疗法的潜力.
主要方法:
- 在T细胞中对PDCD1mRNA的m6A修饰的分析.
- 研究METTL14,YTHDF1/2/3在PDCD1mRNA失稳中的作用.
- 在小鼠模型中评估METTL14缺乏对CD8+T细胞激活和瘤生长的影响.
- 与临床癌症数据和免疫治疗反应相关的METTL14和PDCD1水平.
- 在体内评估METTL3-METTL14复合降解剂 (WD6305) 与抗PD-1治疗的组合.
主要成果:
- 在T细胞中通过m6A修饰调节PDCD1基因表达.
- METTL14通过YTHDF1/ 2/ 3促进PDCD1的m6A依赖性破坏稳定,从而导致PDCD1的下调.
- 由于PD-1水平升高,METTL14缺乏会损害CD8+T细胞的激活,并增强瘤的生长.
- 临床数据显示METTL14和PDCD1水平之间存在负相关性,与PD-1免疫治疗的耐药性相关.
- 联合WD6305和抗PD-1治疗抑制了小鼠的瘤生长.
结论:
- m6A PDCD1的修饰代表了一种影响T细胞功能和瘤免疫力的新型免疫调节机制.
- 针对m6A-PDCD1轴,特别是通过METTL14调制或组合疗法,为增强抗PD-1癌症免疫疗法的有效性提供了一个有希望的策略.
更多相关视频
10:18Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
Published on: July 7, 2023
1.4K
09:15Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
3.5K
相关概念视频
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Tumor Immunotherapy
659
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
659
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
